Conversely, other microbial metabolites, such as imidazole propionate, have been shown to impair insulin signaling and promote IR, further linking gut dysbiosis to the pathogenesis of MetS and MASLD [32,42]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.